Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6 Hydroxydopamine
2. 6-hydroxydopamine
3. 6-ohda
4. Hydrobromide, Oxidopamine
5. Hydrochloride, Oxidopamine
6. Oxidopamine
7. Oxidopamine Hydrobromide
8. Oxidopamine Hydrochloride
1. 636-00-0
2. Oxidopamine Hydrobromide
3. Oxidopamine (hydrobromide)
4. 6-hydroxydopamine Hbr
5. 6-ohda
6. 2,4,5-trihydroxyphenethylamine Hydrobromide
7. 5-(2-aminoethyl)benzene-1,2,4-triol Hydrobromide
8. 6-ohda Hbr
9. Mfcd00012894
10. Twc1d4w0wb
11. 2-(2,4,5-trihydroxyphenyl)ethylamine Hydrobromide
12. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide
13. 6-hydroxydopamine Hydrobromide;6-ohda Hydrobromide
14. Nsc-238469
15. 636-00-0 (hbr)
16. 6-hydroxydopamine Hydrogen Bromide
17. Mls002207128
18. 2,5-dihydroxytyramine Hydrobromide
19. Smr001306725
20. Einecs 211-247-0
21. Unii-twc1d4w0wb
22. Nsc 238469
23. 5-(2-aminoethyl)-4-hydroxypyrocatechol Hydrobromide
24. 5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide
25. 6-ohda Hydrobromide
26. 6-hydroxydopamine.hydrobromide
27. Schembl738049
28. 4-chlorobenzenecarbaldehydeoxime
29. Chembl1718398
30. Hy-b1081a
31. Dtxsid30212972
32. Wln: Z2r Bq Dq Eq &eh
33. Bcp25700
34. Ex-a4152
35. 6-hydroxydopamine Hydrobromide, 95%
36. Nsc238469
37. S5324
38. Akos015916618
39. Ccg-266959
40. Cs-5966
41. As-40064
42. Sy102034
43. Db-054509
44. B7099
45. Ft-0632700
46. M01851
47. 6-ohda Hydrobromide6-hydroxydopamine Hydrobromide
48. A935047
49. 1,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide
50. 5-(2-aminoethyl)-1,2,4-benzenetriol Hydrobromide
51. 6-hydroxydopamine Hydrobromide, >=90% (hplc), Solid
52. Q27290460
53. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide (1:1)
54. 6-ohda Hbr; 6 Ohda Hbr;oxidopamine Hydrobromide; 6-hydroxydopamine Hbr
55. 6-hydroxydopamine Hydrobromide, Contains Ascorbic Acid As Stabilizer, >=98% (hplc)
| Molecular Weight | 250.09 g/mol |
|---|---|
| Molecular Formula | C8H12BrNO3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 249.00006 g/mol |
| Monoisotopic Mass | 249.00006 g/mol |
| Topological Polar Surface Area | 86.7 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 142 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Hydroxydopamine Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxydopamine Hydrobromide, including repackagers and relabelers. The FDA regulates Hydroxydopamine Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxydopamine Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hydroxydopamine Hydrobromide supplier is an individual or a company that provides Hydroxydopamine Hydrobromide active pharmaceutical ingredient (API) or Hydroxydopamine Hydrobromide finished formulations upon request. The Hydroxydopamine Hydrobromide suppliers may include Hydroxydopamine Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxydopamine Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydroxydopamine Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydroxydopamine Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Hydroxydopamine Hydrobromide DMFs exist exist since differing nations have different regulations, such as Hydroxydopamine Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydroxydopamine Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Hydroxydopamine Hydrobromide USDMF includes data on Hydroxydopamine Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydroxydopamine Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydroxydopamine Hydrobromide suppliers with USDMF on PharmaCompass.
Hydroxydopamine Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxydopamine Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxydopamine Hydrobromide GMP manufacturer or Hydroxydopamine Hydrobromide GMP API supplier for your needs.
A Hydroxydopamine Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Hydroxydopamine Hydrobromide's compliance with Hydroxydopamine Hydrobromide specifications and serves as a tool for batch-level quality control.
Hydroxydopamine Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxydopamine Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxydopamine Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxydopamine Hydrobromide EP), Hydroxydopamine Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxydopamine Hydrobromide USP).
LOOKING FOR A SUPPLIER?
